Cost-effectiveness of pretreatment HIV drug resistance testing in people living with HIV in Iran.

ABSTRACT:

Introduction

HIV drug resistance (HIVDR) is an important challenge in the fight against HIV/AIDS and can threaten progress toward achieving the target of HIV elimination by 2030. Genotyping pretreatment HIVDR testing (DRT) has been proposed as a potential solution. However, the cost-effectiveness of this intervention needs to be evaluated to determine its feasibility and potential impact on healthcare systems. This study aimed to assess the cost-effectiveness of DRT among people living with HIV (PLHIV) in Iran.

Methods

1000 hypothetical PLHIV were simulated in terms of cost and effectiveness based on quality-adjusted life Years (QALY). The Markov Model was developed to calculate incremental cost-effectiveness ratio (ICER) using TreeAge Pro 2020. Deterministic and probabilist

SUBMITTER: Mirzaei H 

PROVIDER: S-EPMC11379287 | biostudies-literature | 2024

REPOSITORIES: biostudies-literature